AGLE-102 is under clinical development by Aegle Therapeutics and currently in Phase II for Epidermolysis Bullosa.

School of Chemistry and Chemical Engineering, Institute of Physical Science and Information Technology, Information Materials and Intelligent Sensing Laboratory of Anhui Province, Key Laboratory of ...